This document focuses on LGBT populations and is intended to guide improved service and treatment planning. It describes patterns of club drug use among these sub-populations (Neptune)
Bibliography: All Publications
From Epidemic to Evidence
Effectively Managing The Harms Associated with Crystal Methamphetamine (Drug and Alcohol Research Connections)
Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England
The distribution of THN within a custodial setting requires consideration of a number of important factors which are discussed (HRJ)
After the Drug Wars
Report of the LSE Expert Group on the Economics of Drug Policy
United Kingdom Drug Situation
Annual Report to the European Monitoring Centre for Drugs and Drug Addiction (UK Focal Point On Drugs)
New Report and Monitoring Tool: HIV, HCV, TB and Harm Reduction in Prisons
Even though prisoners do not forfeit their human rights, such as the right to health, there is an enormous gap between health and human rights standards and their effective implementation in places of detention (IHR)
Road to Success: Towards Sustainable Harm Reduction Financing
This report provides guidance, driven by findings from the community of people who inject drugs and their allies, for countries and international partners alike to make this transition (EHRN)
The internet and drug markets
This first EMCDDA investigation into the world of online drug markets brings together state-of-the-art input from over 20 experts — from academia, journalism and frontline practice — and contributes to the knowledge base on this part of the supply chain
Drug Crop Production, Poverty, and Development
This series intends to provide a primer on why governments must not turn a blind eye to pressing human rights and public health impacts of current drug policies (OSF)
EMCDDA activities in the area of emergencies
A unique insight into acute health harms is provided by hospital emergency data, which widen the scope of monitoring health consequences of drug use, beyond other more established indicators (EMCDDA)
Investigating the role of benzodiazepines in drug-related mortalit
A systematic review undertaken on behalf of The Scottish National Forum on Drug-Related Deaths (ScotPHO)
The absorption of recovery in English drug policy
This is an excerpt of a recent NDARC seminar presentation by Professor Alex Stevens (NDARC)
Annual Parliamentary Hearing
“The world drug problem: taking stock and strengthening the global response” (UNODC)
Number of drug driving convictions
It gives the number of drug related driving offences recorded on the drivers database quarterly from 2011 to 2015 (DVLA)
Impact of the reduction in heroin supply between 2010 and 2011
This report makes best use of available secondary data to examine how the reduction in heroin supply in England and Wales manifested itself at street level and to attempt to quantify any impact on drug use and associated harms (Home Office)
Availability of Internationally Controlled Drugs
Ensuring Adequate Access for Medical and Scientific Purposes (INCB)
PHILTRE Annual Report 2014-15
WEDINOS provides a mechanism for the anonymous submission and testing of samples of new psychoactive substances and the dissemination of pragmatic harm reduction advice (NHS Wales)
Use of opioid painkillers increases fourfold in Australia in 10 years while most of the world lacks access to basic painrelief
Use of common opioid painkillers such as codeine, morphine and oxycodone has more than quadrupled in Australia over the past decade and doubled worldwide over the same period a report published today in the Lancet (3rd February 2016) by the International Narcotics Control Board (INCB) reveals (NDARC)
The Association of Directors of Public Health: Position Statement – Take home naloxone
This position statement:
1. provides Directors of Public Health with the ADPH position statement on Naloxone use
2. provides a briefing on take home naloxone schemes and issues for Directors of Public Health to
consider, and
3. provides references and sources for key resources and information
A simple (ish) guide to the Psychoactive Substances Act
The Psychoactive Substances Act will come into force on the 6th April 2016. The Act will make it an offence to produce, supply or offer to supply any psychoactive substance if the substance is likely to be used for its psychoactive effects and regardless of its potential for harm (DrugWatch)
INPUD Submission to the Civil Society Task Force to UNGASS on Drug
The submission of the International Network of People who Use Drugs (INPUD) to the Civil Society Task Force to UNGASS on Drugs 2016 is derived from INPUD’s Consensus Statement on Drug Use Under Prohibition: Human Rights, Health, and the Law (INPUD)
Psychoactive Substances Act 201
This is the original version (as it was originally enacted). This item of legislation is currently only available in its original format (UK Government)
Emerging consensus on measuring addiction recovery
Findings from a multi-stakeholder consultation exercise (Drugs: Education, Prevention and Policy)
2016 United Nations General Assembly Special Session on the World Drug Problem
An opportunity to move towards metrics that measure outcomes that really matter (GDPO)
Drug health harms – national intelligence
Notes reflecting presentations and discussion from the ninth meeting of the National Intelligence Network on the health harms associated with drug use, held in London on 2 December 2015. These notes are for directors of public health, commissioners, service providers and needle and syringe programmes (PHE)
Realising Rights: Developing Human Rights-based Indicators for Drug Control
Briefing for Member States at the International Centre for Science in Drug Policy and UN University event ‘Identifying Common Ground for UNGASS 2016: Rethinking Metrics to Evaluate Drug Policy’ (Harm Reduction International)
New opiate and crack-cocaine users: characteristics and trends
This report uses available data to estimate the number of new users of opiates and, or crack-cocaine (OCUs) between 2005 and 2013 (Home Office)
2016–18 strategy and work programme and 2016 annual work programme
The EMCDDA strategy and work programme for 2016–18 and the 2016 annual work programme is based on the EMCDDA’s vision to contribute to a more secure and a healthier Europe. A more proactive approach, combined with a greater emphasis to knowledge transfer, strategic analysis and threat assessment will be the main drivers to achieve this goal (EMCDDA)
Prisoner mental health
There has been significant movement in policy and practice surrounding the approach to managing mental health needs of prisoners over the last two decades, and some improvement has undoubtedly been made. However, there is still a long way to go, and we hope that the lessons identified in this report can help prisons to re-evaluate and improve their practices where appropriate, amid the complex landscape of mental health provision (Prisons and Probation Ombudsman)
Draft Outcome Document for the UNGASS process
This year sees the final preparations, in terms of reconvened session later this month in Vienna, followed by the Civil Society Hearing in New York on 10th February and the Commission of Narcotic Drugs, to be held in Vienna from 14th – 22nd March (EURAD)
New EMCDDA insights into naloxone, the overdose antidote that can help save lives
This issue is explored today in a new report from the EU drugs agency (EMCDDA) entitled Preventing opioid overdose deaths with take-home naloxone
Drug health harms – national intelligence
Notes reflecting presentations and discussion from the ninth meeting of the National Intelligence Network on the health harms associated with drug use, held in London on 2 December 2015 (PHE)
Cannabis in Indonesia
Patterns in consumption, production, and policies (TNI)
WHO Recommends against International Control of Ketamine
Seven ‘New Psychoactive Substances’ Considered to Pose Health Risks (WHO)
The Psychoactive Substances Bill 2015-16: Report on Committee Stage
This briefing paper is produced prior to the Report Stage of the Psychoactive Substances Bill 2015-16
‘Third generation’ synthetic cannabinoids
Report presented to the crime prevention minister recommends a revised generic description, designed to control a broad-range of ‘third generation’ synthetic cannabinoids (AMCD)
Emergency department-based brief interventions for individuals with substance-related problems: a review of effectiveness
This paper considers five systematic reviews and 16 randomised controlled trials and points to the potential benefits of brief interventions, albeit with a need for more research (EMCDDA
Patient motivations, perceptions and experiences of opioid substitution therapy in prison
This qualitative study aimed to examine patient motivations for, and perceptions and experiences of, OST in prisons in New South Wales, Australia (NDARC)
Local perspectives in Ending Gang and Youth Violence Areas
Perceptions of the nature of urban street gangs (Home Office)
Psychoactive substances bill, as amended
This document includes all amendments tabled to date, arranged in the order they relate to the Bill (Parliament UK)
- « Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 49
- Next Page »
